---
title: "Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes"
ocid: "ocds-h6vhtk-05d3d5"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05d3d5"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-05d3d5.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-05d3d5.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2026-05-18"
---

# Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-05d3d5

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05d3d5)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-05d3d5.json)

## Summary

NHS England, in collaboration with NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), has completed a public procurement process under the Health Care Services (Provider Selection Regime) Regulations 2023, focusing on a specialised adult whole-body MRI (WBMRI) service for cancer predisposing syndromes. This process, in the health services industry category, resulted in an intention to award contracts across seven UK regions, including London, the East of England, and the Midlands, with services set to commence on 1 July 2026. The competitive open procedure was conducted to expand capacity and improve early cancer detection, with contracts having an initial term of three years and a potential extension of two additional years, maximising a five-year duration. Interested providers needed to submit representations by 29 May 2026.

This procurement presents significant opportunities for businesses involved in healthcare services, especially those with expertise in MRI scanning and genetic conditions related to cancer. The open nature of this process encourages diverse provider participation and the opportunity for businesses to establish or expand their footprint in the UK healthcare system. Ideal candidates include large-scale NHS Trusts and healthcare providers capable of maintaining sophisticated imaging operations. The initiative aims to enhance clinical care for patients with inherited cancer syndromes, offering potential growth for businesses that can successfully integrate with regional genetic centres and healthcare networks in delivering high-quality, collaborative patient care services.

## Notice

This is a notice of intention to make an award. NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU),on behalf of NHS England Specialised Commissioning (referred to as the Authority) invited suitably qualified and experienced providers to express interest in the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes by responding to this accreditation process.

Services are being commissioned across seven (7) geographical regions to serve the population of England, as outlined below:

Lot 1: London
Lot 2: East of England
Lot 3: South East
Lot 4: South West
Lot 5: Midlands
Lot 6: North East and Yorkshire
Lot 7: North West

- There is no restriction on the number of sites that may be commissioned.
- Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS).

Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.

Providers will:
* Provide, interpret and report WB-MRI Scanning for the patient cohort described.
* Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible).
* Establish effective pathways (including sharing results) with providers.
* Be linked to regional genetic centres to allow continuity of care.
* Facilitate communication with referrers including consultant clinical geneticists
* Have capacity to plan and undertake WBMRI under general anaesthetic if re-quired.
* Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.
* Engage positively with associated patient support groups.
* Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.
* Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.
* Operate Quality Assessment processes according to CQC standards
* Screening will be in addition to breast screening undertaken through the National VHRS Programme
* Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.
* Support continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.
* Liaise with partners across cancer alliances to support early diagnosis innovation opportunities
* Ensure screening frequency will be in accordance with surveillance protocols.

### Lot Information

Lot 1

This notice sets out the intention to award a contract following a competitive procurement process for the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes.

The Commissioner intends to award 10 individual contracts for this newly commissioned service, following this competitive process, to providers not previously contracted for this service.

Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS).

Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.

Providers will:
* Provide, interpret and report WB-MRI Scanning for the patient cohort described.
* Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible).
* Establish effective pathways (including sharing results) with providers.
* Be linked to regional genetic centres to allow continuity of care.
* Facilitate communication with referrers including consultant clinical geneticists
* Have capacity to plan and undertake WBMRI under general anaesthetic if re-quired.
* Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.
* Engage positively with associated patient support groups.
* Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.
* Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.
* Operate Quality Assessment processes according to CQC standards
* Screening will be in addition to breast screening undertaken through the National VHRS Programme
* Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.
* Support continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.
* Liaise with partners across cancer alliances to support early diagnosis innovation opportunities
* Ensure screening frequency will be in accordance with surveillance protocols.

The approximate total lifetime value of all 10 contracts over the full 5 year contract term is circa PS1,387,430.

The services are intended to commence on 1 July 2026, with an initial contract period to 30 June 2029, and an option to extend for up to a further two years, resulting in a maximum contract term of five years.

The intention to to award contracts to the following providers:
Lot 1 - London
Guy's and St Thomas' NHS Foundation Trust
London North West University Healthcare NHS Trust
The Royal Marsden NHS Foundation Trust
Lot 2 - East of England
Cambridge University Hospitals NHS Foundation Trust
Lot 3 - South East
University Hospitals Southampton NHS Foundation Trust
Lot 4 - South West
Royal Devon University Hospitals Trust
Lot 5 - Midlands
Nottingham University Hospitals NHS Trust Primary
Lot 6 - North East and Yorkshire
Leeds Teaching Hospitals NHS Trust
Sheffield Teaching Hospitals NHS Foundation Trust
Lot 7 - North West
Manchester University NHS Foundation Trust (MFT) Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of these contracts is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. 

Representations by providers must be made to the relevant authority by Friday 29 May 2026. These contracts have not yet formally been awarded; this notice serves as an intention to award under the PSR. Representations should be sent to jessica.gaucher-thompson@nhs.net.

The award decision-makers were NHS England's National Commissioning Group (NCG). 

The award decision was based on the outcome of a pass/fail evaluation against the published procurement requirements.

All key award criteria were assessed on a pass/fail basis and were considered of equal importance.

The providers selected for award successfully met all pass/fail requirements and were therefore assessed as compliant with the mandatory criteria.

Options: Initial period of three (3) years with the Commissioner having the option to extend the Contract for up to a further two (2) years (maximum contract duration 5 years)

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/045358-2026 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 18 May 2026 |
| Submission deadline | 8 Dec 2025 |
| Future notice date | Not specified |
| Award date | 20 Apr 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £3,000,000 |
| Lots value | £3,000,000 |
| Awards value | Not specified |
| Contracts value | £1,387,430 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS1 4AP |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 10 |
| Supplier names | CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST; GUY'S AND ST THOMAS' NHS FOUNDATION TRUST; LEEDS TEACHING HOSPITALS NHS TRUST; LONDON NORTH WEST UNIVERSITY HEALTHCARE NHS TRUST; MANCHESTER UNIVERSITY NHS FOUNDATION TRUST (MFT; NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST PRIMARY; ROYAL DEVON UNIVERSITY HOSPITALS TRUST; SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST; THE ROYAL MARSDEN NHS FOUNDATION TRUST; UNIVERSITY HOSPITALS SOUTHAMPTON |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85100000 - Health services

## Release History

- 18 May 2026 at 12:52 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/045358-2026
- 27 Oct 2025 at 08:56 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/068396-2025

## Notice URLs

- https://health-family.force.com/s/Welcome
- https://www.ardengemcsu.nhs.uk/
- https://www.england.nhs.uk/
- https://www.england.nhs.uk//
- https://www.england.nhs.uk/about/regional-area-teams/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05d3d5. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-05d3d5.json.